Patents Assigned to Dimera Inc.
  • Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease
    Patent number: 7674783
    Abstract: A method for preventing or treating vascular hyperreactivity in which a chemical compound that is an estrogen beta receptor agonist is administered to a subject suffering from or at risk of vascular hyperreactivity. Preferably, the administration is topically to the skin.
    Type: Grant
    Filed: October 21, 2003
    Date of Patent: March 9, 2010
    Assignee: Dimera Inc.
    Inventor: R. Kent Hermsmeyer